Precision Over power

In MedTech, "swinging for the fences" is a liability, not a strategy.description.

Matthias Winker

3/10/20263 min read

Look at the data from my last session at the driving range:

  • The short game (pink/orange): High precision, tight clusters, repeatable outcomes. This is your core product-market fit.

  • The long game (green/yellow): High dispersion, volatile results, massive "miss" potential. This is your attempt at enterprise scaling.

The strategy gap also happens elsewhere:

Most Med/HealthTech companies try to grow by simply hitting the ball harder. They aim for the 180-yard marker with a 42% consistency rate. In a regulated market with high stakes and long sales cycles, that "dispersion" is where burn rate hides and clinical trust dies.

Many companies fail during the commercialisation phase. They spend years focused on product development and neglect their sales infrastructure. The healthcare market punishes unfocused ambition. Bringing a moderate-risk medical device from concept to clearance costs $31 million on average. A standard B2B healthcare sales cycle takes 12 to 18 months. A single hospital purchase requires approval from up to nine different decision-makers. You cannot force your way through this system.

When you spread your resources across too many targets, your win rate drops. You spend months stuck in procurement. Your cash reserves deplete while you wait for signatures.

You need precision. You must narrow your focus and build a repeatable commercial process.

Here is how you execute a precise go-to-market strategy:

Define a narrow target audience

Stop pitching your device to every available hospital. Identify the specific clinical environment where your technology solves an urgent problem. Pick one specific department. Prove your clinical and economic value in that setting first. Secure three successful deployments. Measure the financial impact of your device in those three locations. Use the data from those deployments to build a detailed case study. Buyers trust data from environments that match theirs.

Map the buying committee

Hospital procurement is complex. You must identify every stakeholder involved in the buying decision. The clinical lead wants to improve patient outcomes. The IT director requires data security and easy integration. The CFO demands a clear return on investment. You must write specific messaging for each person. Give the CFO a direct cost-savings model based on actual salary data. Show the clinical lead workflow improvements using time-tracking metrics. Address security protocols early to prevent delays from the IT department. Tailor your presentations to answer their specific questions.

Standardise your pilot programmes

Hospitals use unstructured pilots to delay buying decisions. Companies waste thousands of £/$/E supporting these endless evaluations. You must control the pilot process. Define three measurable success metrics before the pilot begins. Assign a specific hospital employee to own each metric. Set a strict 60-day timeline for the evaluation. Agree on a formal review date to transition the successful pilot into a commercial contract. If a hospital refuses to set clear metrics, walk away. You cannot afford to provide free consulting.

Structure your pricing for procurement

Complex pricing models confuse buyers. Hospital finance teams reject proposals they do not understand. You must simplify your commercial offer. Separate your capital equipment costs from your software subscriptions. Provide a predictable annual fee. Remove variable costs that fluctuate month to month. When a hospital knows exactly what they will pay in year two and year three, they approve contracts faster.

Align your evidence with commercial goals

Regulatory clearance allows you to sell. It does not guarantee adoption. You must generate real-world evidence that supports your commercial claims. Track user adoption rates across different shifts. Measure the minutes saved per procedure. Document reductions in readmission rates. Calculate the reduction in consumable waste. Buyers require this hard data to justify the purchase to their finance committees.

Growth requires discipline. You must build a controlled sales environment. Make your target market small. Make your value proposition exact. Build a system that generates predictable revenue.

This approach protects your capital. It builds credibility with healthcare providers. Precision creates sustainable growth.

At Buoyancy Health Strategy, we don’t help you swing harder. I help you tighten the cluster.

We move your long-range strategy from "hopeful spray" to "clinical precision" by:

  1. Hardening the core: Ensuring your short-game operations are bulletproof.

  2. Reducing variables: Streamlining the commercial path to eliminate the "outliers" that waste capital.

  3. Predictable scaling: Turning that wide green ellipse into a repeatable, narrow target.

If your growth data looks like a shotgun blast, you aren't ready to scale. You're just ready to miss faster.